Memorial Sloan Kettering Cancer Center
2,104
341
736
1,217
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.7%
119 terminated/withdrawn out of 2104 trials
91.1%
+4.6% vs industry average
4%
93 trials in Phase 3/4
36%
439 of 1217 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2104)
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Role: lead
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
Role: lead
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Role: collaborator
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Role: lead
Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer
Role: lead
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Role: collaborator
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Role: collaborator
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Role: lead
A Study of Isoquercetin in People With Ovarian Cancer
Role: lead
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Role: lead
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Role: lead
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Role: lead
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Role: collaborator
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
Role: lead
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Role: lead
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Role: lead
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
Role: lead
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
Role: collaborator
Implementation and Effectiveness Trial of HN-STAR
Role: collaborator
Exercise and QUality Diet After Leukemia: The EQUAL Study
Role: lead